Seward Jane F, Zhang John X, Maupin Teresa J, Mascola Laurene, Jumaan Aisha O
Centers for Disease Control and Prevention, Atlanta, Ga 30333, USA.
JAMA. 2004 Aug 11;292(6):704-8. doi: 10.1001/jama.292.6.704.
Limited data are available on the contagiousness of vaccinated varicella cases.
To describe secondary attack rates within households according to disease history and vaccination status of the primary case and household contacts and to estimate varicella vaccine effectiveness.
DESIGN, SETTING, AND PATIENTS: Population-based, active varicella surveillance project in a community of approximately 320,000 in Los Angeles County, California, during 1997 and 2001. Varicella cases were reported by child care centers, private and public schools, and health care clinicians and were investigated to collect demographic, clinical, medical, and vaccination data. Information on household contacts' age, varicella history, and vaccination status was collected.
Varicella secondary attack rate among household contacts; vaccine effectiveness using secondary attack rates in unvaccinated and vaccinated children and adolescents.
A total of 6316 varicella cases were reported. Among children and adolescents aged 1 to 14 years, secondary attack rates varied according to age and by disease and vaccination status of the primary case and exposed household contacts. Among contacts aged 1 to 14 years exposed to unvaccinated cases, the secondary attack rate was 71.5% if they were unvaccinated and 15.1% if they were vaccinated (risk ratio [RR], 0.21; 95% confidence interval [CI], 0.15-0.30). Overall, vaccinated cases were half as contagious as unvaccinated cases. However, vaccinated cases with 50 lesions or more were similarly contagious as unvaccinated cases whereas those with fewer than 50 lesions were only one third as contagious (secondary attack rate, 23.4%; RR, 0.32 [95% CI, 0.19-0.53]). Vaccine effectiveness for prevention of all disease was 78.9% (95% CI, 69.7%-85.3%); moderate disease, 92% (50-500 lesions) and 100% (clinician visit); and severe disease, 100%.
Under conditions of intense exposure, varicella vaccine was highly effective in preventing moderate and severe disease and about 80% effective in preventing all disease. Breakthrough varicella cases in household settings were half as contagious as unvaccinated persons with varicella, although contagiousness varied with numbers of lesions.
关于接种水痘疫苗病例的传染性,现有数据有限。
根据首例病例及家庭接触者的疾病史和疫苗接种状况,描述家庭内的二代发病率,并估算水痘疫苗的有效性。
设计、地点和患者:1997年至2001年期间,在加利福尼亚州洛杉矶县一个约有32万人口的社区开展的基于人群的水痘主动监测项目。水痘病例由日托中心、私立和公立学校以及医疗保健临床医生报告,并进行调查以收集人口统计学、临床、医疗和疫苗接种数据。收集了家庭接触者的年龄、水痘病史和疫苗接种状况信息。
家庭接触者中的水痘二代发病率;利用未接种疫苗和接种疫苗的儿童及青少年的二代发病率计算疫苗有效性。
共报告了6316例水痘病例。在1至14岁的儿童和青少年中,二代发病率因年龄以及首例病例和暴露的家庭接触者的疾病及疫苗接种状况而异。在1至14岁接触未接种疫苗病例的接触者中,未接种疫苗者的二代发病率为71.5%,接种疫苗者为15.1%(风险比[RR],0.21;95%置信区间[CI],0.15 - 0.30)。总体而言,接种疫苗的病例传染性是未接种疫苗病例的一半。然而,有50个或更多皮疹的接种疫苗病例的传染性与未接种疫苗病例相似,而皮疹少于50个的接种疫苗病例的传染性仅为未接种疫苗病例的三分之一(二代发病率,23.4%;RR,0.32[95%CI,0.19 - 0.53])。预防所有疾病的疫苗有效性为78.9%(95%CI,69.7% - 85.3%);预防中度疾病(50 - 500个皮疹)的有效性为92%,预防需临床就诊的疾病的有效性为100%;预防重度疾病的有效性为100%。
在密切接触情况下,水痘疫苗在预防中度和重度疾病方面非常有效,在预防所有疾病方面约80%有效。家庭环境中的突破性水痘病例的传染性是未接种疫苗的水痘患者的一半,不过传染性因皮疹数量而异。